An academic spin-off biotech with only a handful of people on board was preparing for their new biological entity for clinical development. For the drug product itself, they needed to a CMC process and conduct necessary nonclinical studies. To make all these happen, they needed to raise the necessary funds. This is where the client came across challenges.
